Skip to main content
logo
Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0120
-0.0010 (-7.69%)
Aug 5, 2026, 1:13 PM AEST

Cynata Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
1.691.892.321.657.771.55
Revenue Growth
-10.50%-18.59%39.98%-78.71%402.60%-77.95%
Gross Profit
1.691.892.321.657.771.55
Operating Income
-8.62-9.61-10.23-14.89-6.07-7.53
Net Income
-8.4-9.39-9.74-14.28-5.45-7.69
Earnings Per Share
-0.04-0.05-0.05-0.10-0.04-0.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
2.595.056.2116.1723.826.72
Total Debt
------
Net Cash (Debt)
2.595.056.2116.1723.826.72
Net Cash Growth
-48.74%-18.62%-61.62%-32.06%-10.92%95.73%
Net Cash Per Share
0.010.020.030.110.170.20

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-8.18-8.72-9.96-14.28-3.3-5.16
Free Cash Flow
-8.18-8.72-9.96-14.28-3.3-5.16
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-511.09%-509.82%-441.78%-899.97%-78.09%-487.33%
Pretax Margin
-498.03%-498.14%-420.82%-863.05%-70.08%-497.38%
Profit Margin
-498.03%-498.14%-420.82%-863.05%-70.08%-497.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-103.85103.85103.85103.85103.85
PS Ratio
1.7317.9822.8813.576.6446.80